Inhibition of apoE-SDC4 interactions by using antibodies, peptides, or small molecules could represent a novel strategy in difficult-to-treat patients and prevent infection post liver graft infection, a procedure without preventive strategies and unsatisfactory treatment options [42], [43]. This evidence concerns the gene SDC4 and infection.